Related Experiment Video
Updated: Jun 12, 2026
07:19
Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
Myofascial trigger points. What physicians should know about these neurological imitators
1Minneapolis Clinic of Neurology, USA.
Minnesota Medicine
|June 25, 2010
Summary
Myofascial trigger points (MFTPs) cause chronic pain and neurological symptoms like headaches and dizziness. Recognizing these musculoskeletal origins is crucial for accurate diagnosis and treatment.
Area of Science:
- Neurology
- Musculoskeletal Medicine
- Pain Management
Background:
- Myofascial trigger points (MFTPs) are a frequent source of chronic neck and back pain.
- MFTPs can manifest a diverse range of associated symptoms, including neurological disturbances.
Purpose of the Study:
- This review examines the neurological symptoms associated with musculoskeletal MFTPs.
- Focus is placed on headache, dizziness, and sensory disturbances.
- The review aims to elucidate the diagnosis, pathophysiology, and treatment of MFTPs.
Main Methods:
- Literature review focusing on MFTPs and associated neurological symptoms.
- Analysis of proposed mechanisms linking musculoskeletal MFTPs to neurological manifestations.
- Discussion of diagnostic and therapeutic strategies.
Main Results:
- Musculoskeletal MFTPs are implicated in causing neurological symptoms such as headache, dizziness, and sensory disturbances.
- Understanding the pathophysiology is key to differentiating these symptoms from other neurological disorders.
- Effective treatment of MFTPs may alleviate these associated neurological symptoms.
Conclusions:
- Physicians should consider MFTPs as a potential cause of unexplained neurological symptoms.
- Early diagnosis and targeted treatment of MFTPs can improve patient outcomes.
- This highlights the importance of a comprehensive approach to patients presenting with chronic pain and neurological complaints.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:29Tetanus
Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...